000 01159 a2200325 4500
005 20250514031958.0
264 0 _c20020613
008 200206s 0 0 eng d
022 _a0007-1250
024 7 _a10.1192/bjp.180.5.466-a
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWalsh, E
245 0 0 _aProlonged QT interval with rivastigmine.
_h[electronic resource]
260 _bThe British journal of psychiatry : the journal of mental science
_cMay 2002
300 _a466 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAged
650 0 4 _aAlzheimer Disease
_xdrug therapy
650 0 4 _aCarbamates
_xadverse effects
650 0 4 _aCholinesterase Inhibitors
_xadverse effects
650 0 4 _aHumans
650 0 4 _aLong QT Syndrome
_xchemically induced
650 0 4 _aMale
650 0 4 _aNeuroprotective Agents
_xadverse effects
650 0 4 _aPhenylcarbamates
650 0 4 _aRivastigmine
700 1 _aDourish, J
773 0 _tThe British journal of psychiatry : the journal of mental science
_gvol. 180
_gp. 466
856 4 0 _uhttps://doi.org/10.1192/bjp.180.5.466-a
_zAvailable from publisher's website
999 _c11883820
_d11883820